Dialysis patients may be overmedicated
Changes in a widely used assay (blood test) for parathyroid hormone (PTH) have made its use with the established guidelines for end stage renal disease clinical management both inappropriate and...
View ArticleMinimally invasive parathyroidectomy under local/sedation
Parathyroidectomy is the removal of one or more of the parathyroid glands to treat hyperparathyroidism (abnormal over-functioning of the parathyroid glands).
View ArticleADVANCE study provides new insights into the management of SHPT in CKD patients
Results from the ADVANCE study presented in a late breaking clinical trial session at the ERA-EDTA 2010 Congress provide new insights into the management of secondary hyperparathyroidism in chronic...
View ArticleLiving-donor parathyroid gland transplant allows young woman to forgo 60...
Surgeons at the University of Illinois Hospital & Health Sciences System performed a rare living-donor parathyroid gland transplant to help a 22-year-old woman maintain normal calcium levels...
View ArticleOne-side parathyroid surgery has poorer long-term outcomes
Dr James Norman, MD and his partners at the Norman Parathyroid Center have published a landmark study in this week's Journal of the American College of Surgeons describing how the operation they...
View ArticlePositive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction...
View ArticleStudy explores advantages of minimally invasive parathyroidectomy for...
An open surgical procedure called bilateral neck exploration has been the gold standard operation for treating patients with primary hyperparathyroidism. But the development of a minimally invasive...
View ArticleAmgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide
Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency via the centralized procedure for etelcalcetide (formerly AMG 416) for the treatment...
View ArticleSurgery more effective than drug therapy in patients with tertiary...
A study led by researchers from the Nephrology group at Bellvitge Biomedical Research Institute (IDIBELL) and the University Hospital of Bellvitge (HUB), compared the results of surgery with drug...
View ArticleNew prognostic tool accurately predicts recurrence of parathyroid cancer
A newly-created prognostic tool reliably predicts the recurrence of parathyroid cancer, enabling physicians to identify patients at the highest risk.
View ArticleDialysis patients may be overmedicated
Changes in a widely used assay (blood test) for parathyroid hormone (PTH) have made its use with the established guidelines for end stage renal disease clinical management both inappropriate and...
View ArticleMinimally invasive parathyroidectomy under local/sedation
Parathyroidectomy is the removal of one or more of the parathyroid glands to treat hyperparathyroidism (abnormal over-functioning of the parathyroid glands).
View ArticleADVANCE study provides new insights into the management of SHPT in CKD patients
Results from the ADVANCE study presented in a late breaking clinical trial session at the ERA-EDTA 2010 Congress provide new insights into the management of secondary hyperparathyroidism in chronic...
View ArticleLiving-donor parathyroid gland transplant allows young woman to forgo 60...
Surgeons at the University of Illinois Hospital & Health Sciences System performed a rare living-donor parathyroid gland transplant to help a 22-year-old woman maintain normal calcium levels...
View ArticleOne-side parathyroid surgery has poorer long-term outcomes
Dr James Norman, MD and his partners at the Norman Parathyroid Center have published a landmark study in this week's Journal of the American College of Surgeons describing how the operation they...
View ArticlePositive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction...
View ArticleStudy explores advantages of minimally invasive parathyroidectomy for...
An open surgical procedure called bilateral neck exploration has been the gold standard operation for treating patients with primary hyperparathyroidism. But the development of a minimally invasive...
View ArticleAmgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide
Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency via the centralized procedure for etelcalcetide (formerly AMG 416) for the treatment...
View ArticleSurgery more effective than drug therapy in patients with tertiary...
A study led by researchers from the Nephrology group at Bellvitge Biomedical Research Institute (IDIBELL) and the University Hospital of Bellvitge (HUB), compared the results of surgery with drug...
View ArticleNew prognostic tool accurately predicts recurrence of parathyroid cancer
A newly-created prognostic tool reliably predicts the recurrence of parathyroid cancer, enabling physicians to identify patients at the highest risk.
View Article
